Comparative analysis of three decades; experience in the management of pregnant women with epilepsy: a real-life scenario

被引:1
|
作者
Valoczy, Reka [1 ]
Fekete, Istvan [2 ]
Horvath, Laszlo [3 ]
Meszaros, Zsofia [2 ]
Fekete, Klara [2 ]
机构
[1] Univ Debrecen, Fac Med, Doctoral Sch Neurosc, Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Neurol, Debrecen, Hungary
[3] Univ Debrecen, Fac Pharm, Dept Pharmaceut Surveillance & Econ, Debrecen, Hungary
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
pregnancy; antiseizure medication; seizure; women with epilepsy (WWE); Epilepsy Care; ANTIEPILEPTIC DRUGS; INTERNATIONAL LEAGUE; ANTERIOR NUCLEUS; SEIZURE CONTROL; TERATOGENICITY; MALFORMATIONS; STIMULATION; DELIVERY; MORTALITY; RISKS;
D O I
10.3389/fneur.2023.1254214
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: People with epilepsy have to face many challenges, including regular follow-ups, the need to take antiseizure medications (ASMs), and the fear of seizures. Pregnant women with epilepsy (PWWE) are a special group with even more challenges because they are responsible for the fetus. We aimed to evaluate the change in the frequency of pregnancies over the years and the possible role of newer types of ASMs concerning this change, the shift in medication use over three decades, and their possible impact on the outcome of the observed pregnancies.Methods: Data were retrieved from the prospective Epilepsy Database of the Outpatient Clinic at our tertiary center between 1 January 1992 and 31 December 2020. Groups were formed for comparison in time and depending on whether regular care consultation was our task. Statistical analysis was carried out using Microsoft Office Excel 2021. Basic statistics and categorical variables were assessed using Pearson's chi(2) test with Yates' correction. Differences were considered significant if the p-value was <0.05. The odds ratio and 95% confidence intervals were calculated wherever needed.Results: Altogether, 181 pregnancies were studied, mostly after 2002. The regular follow-up group consisted of 101 patients, with 44.5% presenting in the first trimester. The majority of seizures were either generalized or focal to bilateral tonic-clonic seizure types (85.6%). Pregnancies ended in live births in 91.7%, which gradually improved over time, while spontaneous abortion did not differ significantly in the time interval groups. Mostly, monotherapy was provided. PWWEs had higher chances for seizure freedom in the regular-care group I: OR = 2.9 (2.15-3.65) p < 0.0001. A shift toward newer-type ASMs was found as time passed. Levetiracetam and lamotrigine were more commonly used in the regular care group I than by those patients who were sent to consultation only and not treated at our center [OR = 3.18 (2.49-3.87)] p < 0.0001.Conclusion: This is the first study in our region to evaluate experience in the treatment and outcome of PWWE. Having received reliable care and safer ASMs, the number of pregnancies among PWWEs grew. Data suggested that specialized centers' care offered cooperation with obstetricians is important. Moreover, professional care can also enable PWWEs to have uneventful pregnancies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] ELECTRIC VEHICLE AND MANAGEMENT OF ITS AUTONOMY: A PROSPECTIVE APPROACH ANCHORED IN A REAL-LIFE EXPERIENCE
    Nguyen, C.
    Cahour, B.
    TRAVAIL HUMAIN, 2014, 77 (01): : 63 - 89
  • [32] Azithromycin in the Management of Upper Respiratory Tract Infections (URTIs): Indian Real-Life Experience
    Dominic, Mathew
    Srivastava, Rakesh
    Shah, Kshitij
    Naik, Sudhir M.
    Rout, Khageswar
    Ray, Bidhan
    Patil, Dinesh
    Rana, Darshan
    Swami, Onkar C.
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 523 - 531
  • [33] MANAGEMENT OF ANEMIA IN MYELOFIBROSIS: A MULTICENTER REAL-LIFE EXPERIENCE WITH BIOSIMILAR ERYTHROPOIESIS STIMULANTING AGENTS
    Inzoli, E.
    Crisa, E.
    Pugliese, N.
    Civettini, I.
    Lanzarone, G.
    Martinelli, V.
    Gambacorti-Passerini, C.
    Elli, E. M.
    HAEMATOLOGICA, 2021, 106 (10) : 104 - 104
  • [34] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 140 - 140
  • [35] Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis
    Moschouri, Eleni
    Salemme, Gloria
    Baserga, Adriana
    Cerny, Andreas
    Deibel, Ansgar
    Meier, Marie-Anne
    Bernsmeier, Christine
    Ongaro, Marie
    Negro, Francesco
    Grosjean, Marielle
    Clerc, Olivier
    Kuenzler-Heule, Patrizia
    Semela, David
    Hobi, Gabriel
    Stickel, Felix
    Mathieu, Adeline
    Mdawar-Bailly, Elise
    Faouzi, Mohamed
    Moradpour, Darius
    Fragaa, Montserrat
    SWISS MEDICAL WEEKLY, 2024, 154 : 3698
  • [36] Prospective Analysis in Patients With HAE Under Prophylaxis With Lanadelumab: A Real-life Experience
    Hahn, Janina
    Trainotti, Susanne
    Wigand, Marlene C.
    Schuler, Patrick J.
    Hoffmann, Thomas K.
    Greve, Jens
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (10) : 978 - 983
  • [37] Comparative analysis of the behavior of AMR position sensors in real-life magnetic fields
    Dimitrova, P.
    Andreev, S.
    Popova, L.
    JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS, 2007, 9 (02): : 319 - 322
  • [38] Capacity Mechanisms in Europe and the US: A Comparative Analysis and a Real-Life Application for Greece
    Simoglou, Christos K.
    Biskas, Pandelis N.
    ENERGIES, 2023, 16 (02)
  • [39] Comparative analysis for traffic flow forecasting models with real-life data in Beijing
    Rong, Yaping
    Zhang, Xingchen
    Feng, Xuesong
    Ho, Tin-kin
    Wei, Wei
    Xu, Dejie
    ADVANCES IN MECHANICAL ENGINEERING, 2015, 7 (12)
  • [40] Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
    Spagnolo, Calogera Claudia
    Giuffrida, Giuseppe
    Cannavo, Salvatore
    Franchina, Tindara
    Silvestris, Nicola
    Ruggeri, Rosaria Maddalena
    Santarpia, Mariacarmela
    CANCERS, 2023, 15 (01)